Transforming growth factor β (TGF-β) signaling plays a fundamental role in metazoan development and tissue homeostasis. However, the molecular mechanisms concerning the ubiquitin-related dynamic regulation of TGF-β signaling are not thoroughly understood. Using a combination of proteomics and an siRNA screen, we identify pVHL as an E3 ligase for SMAD3 ubiquitination. We show that pVHL directly interacts with conserved lysine and proline residues in the MH2 domain of SMAD3, triggering degradation. As a result, the level of pVHL expression negatively correlates with the expression and activity of SMAD3 in cells, Drosophila wing, and patient tissues. In Drosophila, loss of pVHL leads to the up-regulation of TGF-β targets visible in a downward wing blade phenotype, which is rescued by inhibition of SMAD activity. Drosophila pVHL expression exhibited ectopic veinlets and reduced wing growth in a similar manner as upon loss of TGF-β/SMAD signaling. Thus, our study demonstrates a conserved role of pVHL in the regulation of TGF-β/SMAD3 signaling in human cells and Drosophila wing development.
Skip Nav Destination
Article navigation
3 January 2022
Article|
December 03 2021
pVHL-mediated SMAD3 degradation suppresses TGF-β signaling
Jun Zhou
,
1
School of Biomedical Sciences, Hunan University, Changsha, China
6Division of Signaling and Functional Genomics, Department of Cell and Molecular Biology, Medical Faculty Mannheim, German Cancer Research Center and Heidelberg University, Heidelberg, Germany
Search for other works by this author on:
Yasamin Dabiri,
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Search for other works by this author on:
Rodrigo A. Gama-Brambila,
Rodrigo A. Gama-Brambila
3
Buchmann Institute for Molecular Life Sciences, Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Frankfurt am Main, Germany
Search for other works by this author on:
Shahrouz Ghafoory,
Shahrouz Ghafoory
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Search for other works by this author on:
Mukaddes Altinbay
,
Mukaddes Altinbay
3
Buchmann Institute for Molecular Life Sciences, Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Frankfurt am Main, Germany
Search for other works by this author on:
Arianeb Mehrabi,
Arianeb Mehrabi
4
Department of General, Visceral and Transplantation Surgery, Heidelberg University, Heidelberg, Germany
Search for other works by this author on:
Mohammad Golriz,
Mohammad Golriz
4
Department of General, Visceral and Transplantation Surgery, Heidelberg University, Heidelberg, Germany
Search for other works by this author on:
Biljana Blagojevic,
Biljana Blagojevic
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Search for other works by this author on:
Stefanie Reuter
,
Stefanie Reuter
5
Universitätsklinikum Jena, Klinik für Innere Medizin III, Jena, Germany
Search for other works by this author on:
Kang Han,
Kang Han
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Search for other works by this author on:
Anna Seidel
,
Anna Seidel
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Search for other works by this author on:
Ivan Đikić
,
Ivan Đikić
3
Buchmann Institute for Molecular Life Sciences, Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Frankfurt am Main, Germany
Search for other works by this author on:
Stefan Wölfl,
Stefan Wölfl
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Search for other works by this author on:
Xinlai Cheng
Xinlai Cheng
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
3
Buchmann Institute for Molecular Life Sciences, Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Frankfurt am Main, Germany
Search for other works by this author on:
1
School of Biomedical Sciences, Hunan University, Changsha, China
6Division of Signaling and Functional Genomics, Department of Cell and Molecular Biology, Medical Faculty Mannheim, German Cancer Research Center and Heidelberg University, Heidelberg, Germany
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Rodrigo A. Gama-Brambila
3
Buchmann Institute for Molecular Life Sciences, Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Frankfurt am Main, Germany
Shahrouz Ghafoory
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Mukaddes Altinbay
3
Buchmann Institute for Molecular Life Sciences, Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Frankfurt am Main, Germany
Arianeb Mehrabi
4
Department of General, Visceral and Transplantation Surgery, Heidelberg University, Heidelberg, Germany
Mohammad Golriz
4
Department of General, Visceral and Transplantation Surgery, Heidelberg University, Heidelberg, Germany
Biljana Blagojevic
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Stefanie Reuter
5
Universitätsklinikum Jena, Klinik für Innere Medizin III, Jena, Germany
Kang Han
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Anna Seidel
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Ivan Đikić
3
Buchmann Institute for Molecular Life Sciences, Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Frankfurt am Main, Germany
Stefan Wölfl
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
Xinlai Cheng
2
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
3
Buchmann Institute for Molecular Life Sciences, Pharmaceutical Chemistry, Goethe University Frankfurt am Main, Frankfurt am Main, Germany
Correspondence to X. Cheng: cheng@pharmchem.uni-frankfurt.de
*
J. Zhou and Y. Dabiri contributed equally to this paper.
Y. Dabiri's present address is Georg-Speyer-Haus Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany.
I. Đikić's and X. Cheng's present address is Frankfurt Cancer Institute, Frankfurt, Germany.
Received:
December 19 2020
Revision Received:
June 07 2021
Accepted:
October 13 2021
Online Issn: 1540-8140
Print Issn: 0021-9525
Funding
Funder(s):
German Research Foundation
- Award Id(s): CH 1690/2-1,1690/2-3
Funder(s):
German Federal Ministry of Education and Research
- Award Id(s): 03ZU1109EA
Funder(s):
LOEWE Center Frankfurt Cancer Institute
Funder(s):
Hessen State Ministry for Higher Education, Research and the Arts
- Award Id(s): III L 5-519/03/03.001-0015
© 2021 Zhou et al.
2021
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
J Cell Biol (2022) 221 (1): e202012097.
Article history
Received:
December 19 2020
Revision Received:
June 07 2021
Accepted:
October 13 2021
Citation
Jun Zhou, Yasamin Dabiri, Rodrigo A. Gama-Brambila, Shahrouz Ghafoory, Mukaddes Altinbay, Arianeb Mehrabi, Mohammad Golriz, Biljana Blagojevic, Stefanie Reuter, Kang Han, Anna Seidel, Ivan Đikić, Stefan Wölfl, Xinlai Cheng; pVHL-mediated SMAD3 degradation suppresses TGF-β signaling. J Cell Biol 3 January 2022; 221 (1): e202012097. doi: https://doi.org/10.1083/jcb.202012097
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your Institution
933
Views
0
Citations
Advertisement
Advertisement